Please use this identifier to cite or link to this item:
Title: The Impact of Training Modalities on the Clinical Benefits of Exercise Intervention in Patients with Cardiovascular Disease Risk or Type 2 Diabetes Mellitus
Authors: HANSEN, Dominique 
van Loon, Luc J. C.
Meeusen, Romain
Issue Date: 2010
Publisher: ADIS INT LTD
Source: SPORTS MEDICINE, 40(11). p. 921-940
Abstract: Exercise training intervention represents an effective means to reduce adipose tissue mass, improve glycaemic control and increase whole-body oxygen uptake capacity (VO(2)peak) in obesity, metabolic syndrome, type 2 diabetes mellitus (T2DM) and heart disease patients In this manuscript, we review the impact of different exercise training modalities on clinical benefits of pro longed exercise intervention in these patient (sub)populations By changing training modalities, significantly greater clinical benefits can be obtained Greater training frequency and longer programme duration is associated with greater reduction in adipose tissue mass in obesity patients A greater training frequency (up to 2 days/week) and a longer programme duration (up to 38 weeks) seems to be associated with greater improvements in VO2peak in heart disease patients Longer programme duration and addition of resistance-type exercise further improve glycaemic control in T2DM patients The first line of evidence seems to indicate that high-intensity interval exercise training has a greater impact on VO2peak in heart disease patients and insulin sensitivity in subjects with metabolic syndrome, but not on adipose tissue mass in obese subjects However, it remains unclear whether addition of resistance-type exercise and continuous higher-intensity endurance-type exercise training are accompanied by greater improvements in VO2peak in heart disease patients Furthermore, the impact of training session duration/volume on adipose tissue mass loss and glycaemic control in obesity and T2DM patients, respectively, is currently unknown The impact of training frequency on glycaemic control remains to be investigated in T2DM patients
Notes: [Hansen, Dominique; Dendale, Paul] Jessa Hosp, Heart Ctr Hasselt, Hasselt, Belgium. [Hansen, Dominique; Dendale, Paul] Hasselt Univ, Fac Med, Diepenbeek, Belgium. [Hansen, Dominique] PHL Univ Coll, Rehabil & Healthcare Res Ctr, Dept Healthcare, Hasselt, Belgium. [van Loon, Luc J. C.] Maastricht Univ Med Ctr, Dept Human Movement Sci, Nutr & Toxicol Res Inst NUTRIM, Maastricht, Netherlands. [Meeusen, Romain] Vrije Univ Brussel, Dept Human Physiol & Sports Med, B-1050 Brussels, Belgium.
Document URI:
ISSN: 0112-1642
e-ISSN: 1179-2035
ISI #: 000284301600003
Category: A1
Type: Journal Contribution
Validations: ecoom 2011
Appears in Collections:Research publications

Files in This Item:
File Description SizeFormat 
hansen et al sports med 2010.pdf
  Restricted Access
178.51 kBAdobe PDFView/Open    Request a copy
Show full item record


checked on May 22, 2022

Page view(s)

checked on May 22, 2022


checked on May 22, 2022

Google ScholarTM


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.